Answers are grounded in this paper and cite their sources.
Inhibition of the receptor tyrosine kinase MerTK by small molecules has the potential to augment the immune response to tumors. Potent, selective inhibitors with high levels of
No takes yet. Share an insight, caveat, or question.
Frey et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: